Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Li, Shuang-Jiang; Huang, Jian; Zhou, Xu-Dong; Zhang, Wen-Biao; Lai, Yu-Tian; Che, Guo-Wei

Li, Shuang-Jiang; Huang, Jian; Zhou, Xu-Dong; Zhang, Wen-Biao; Lai, Yu-Tian; Che, Guo-Wei.

Afiliação

Li SJ; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Huang J; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhou XD; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhang WB; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Lai YT; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Che GW; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

J Thorac Dis ; 8(7): 1587-600, 2016 Jul.

Article em En | MEDLINE | ID: mdl-27499947

Palavras-chave

Octamer-binding transcription factor 4 (Oct-4); meta-analysis; non-small cell lung cancer (NSCLC); prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Revista: J Thorac Dis Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google